Eli Lilly and Company (LLY) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

66 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

9.26 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

7/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-1.89 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Eli Lilly and Company's Closelook quality reading?

The composite reads 66/100 across 7 modules, as of 2026-08-06: valuation 37, quality 92, growth 91, balance sheet 59, cash quality 22, capital allocation 57, momentum 70. Closelook scores are research diary readings, not ratings or investment advice.

What is Eli Lilly and Company's Altman Z-Score?

9.26, which sits in the safe zone (above 2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Eli Lilly and Company's Piotroski F-Score?

7 of 9, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Eli Lilly and Company's Beneish M-Score indicate?

-1.89 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelook universe